文献速递心脑血管急症重症综合管理与镇静镇痛

心房颤动患者卒中取栓术后的结局:系统评价与Meta分析

Outcomes of Patients With Atrial Fibrillation Following Thrombectomy for Stroke: A Systematic Review and Meta-analysis.
PubMed 文献 · JAMA Netw Open · 2023-01-03
一句话结论系统评价与Meta分析显示,心房颤动患者机械取栓后90天功能结局更差、死亡率更高,但成功再灌注率与症状性颅内出血率与无心房颤动者相似。

该系统评价与Meta分析检索Web of Science、Embase、Scopus和PubMed(自建库至2022年7月14日),纳入10项研究共6543例因急性缺血性卒中接受机械取栓的患者,比较心房颤动与无心房颤动患者的结局。汇总分析显示两组90天改良Rankin量表(mRS)0~2分率无显著差异(OR 0.72,95%CI 0.47-1.10,P=.13),但敏感性分析后心房颤动组显著更低(OR 0.65,95%CI 0.52-0.81,P<.001);成功再灌注率(OR 1.11,95%CI 0.78-1.58,P=.57)与症状性颅内出血率(OR 1.05,95%CI 0.84-1.31,P=.68)两组相似;心房颤动组死亡率显著更高(OR 1.47,95%CI 1.12-1.92,P=.005)。作者认为心房颤动患者更差的90天结局可能与年龄更大和合并症更多有关。

要点

  • 心房颤动患者取栓后90天mRS 0~2分率在敏感性分析后显著低于无心房颤动者(OR 0.65,95%CI 0.52-0.81,P<.001)。
  • 心房颤动组90天死亡率显著更高(OR 1.47,95%CI 1.12-1.92,P=.005)。
  • 成功再灌注率(TICI 2b~3)两组相似(OR 1.11,95%CI 0.78-1.58,P=.57)。
  • 症状性颅内出血率两组相似(OR 1.05,95%CI 0.84-1.31,P=.68)。
  • 心房颤动患者平均年龄大10.17岁(95%CI 8.11-12.23,P<.001),高血压(OR 1.89,95%CI 1.57-2.27,P<.001)和糖尿病(OR 1.16,95%CI 1.02-1.31,P=.02)比例更高。

适用人群与场景

  • 因急性缺血性卒中接受机械取栓、伴有或不伴有心房颤动的患者。

研究设计与关键结果

  • 研究类型为系统评价与Meta分析,最终纳入10项研究、共6543例患者。
  • 心房颤动组较无心房颤动组平均年龄大10.17岁(95%CI 8.11-12.23,P<.001),高血压比例更高(OR 1.89,95%CI 1.57-2.27,P<.001),糖尿病比例更高(OR 1.16,95%CI 1.02-1.31,P=.02)。
  • 总体分析中,两组90天mRS 0~2分率无显著差异(OR 0.72,95%CI 0.47-1.10,P=.13),纳入研究间存在显著异质性。
  • 敏感性分析后,心房颤动组90天mRS 0~2分率显著低于无心房颤动组(OR 0.65,95%CI 0.52-0.81,P<.001)。
  • 成功再灌注(TICI 2b~3)率两组相似(OR 1.11,95%CI 0.78-1.58,P=.57)。
  • 症状性颅内出血率两组相似(OR 1.05,95%CI 0.84-1.31,P=.68)。
  • 心房颤动组死亡率显著高于无心房颤动组(OR 1.47,95%CI 1.12-1.92,P=.005)。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,数据采用随机效应模型合并,报告遵循PRISMA指南。
  • 局限:总体分析中纳入研究间存在显著异质性(原文未报告具体I²值);作者认为更差的90天结局可能与心房颤动患者年龄更大和合并症更多有关。

对床旁实践的改变

  • 对心房颤动合并急性缺血性卒中接受机械取栓的患者,应关注其年龄更大、高血压和糖尿病比例更高的特点,以及更高的死亡风险。
  • 心房颤动患者取栓后成功再灌注率与症状性颅内出血率与无心房颤动者相似,提示取栓操作本身的安全性与再灌注效果在心房颤动患者中未见明显劣势。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Patients with atrial fibrillation (AF) treated with mechanical thrombectomy (MT) for acute ischemic stroke (AIS) have been reported to experience worse outcomes compared with patients without AF.

OBJECTIVE: To assess differences between patients with AF and their counterparts without AF treated with MT for AIS, focusing on safety outcomes, clinical outcomes, and baseline characteristics in both groups.

DATA SOURCES: A systematic literature review of the English language literature from inception to July 14, 2022, was conducted using Web of Science, Embase, Scopus, and PubMed databases.

STUDY SELECTION: Studies that focused on patients with and without AF treated with MT for AIS were included. Multiple reviewers screened studies to identify studies included in analysis.

DATA EXTRACTION AND SYNTHESIS: Data were extracted following the Preferred Reporting Items for Systematic Reviews and Meta-analyses reporting guideline to ensure accuracy. Data were pooled using a random-effects model.

MAIN OUTCOMES AND MEASURES: The primary outcome of interest was rate of modified Rankin Scale (mRS) scores of 0 to 2 at 90 days. Secondary outcomes of interest included rates of successful reperfusion, defined as thrombolysis in cerebral infarction (TICI) scores of 2b to 3, 90-day mortality, symptomatic intracranial hemorrhage (SICH), and baseline patient characteristics.

RESULTS: Of 1696 initially retrieved studies, 10 studies were included, with 6543 patients. Patients with AF were a mean of 10.17 (95% CI, 8.11-12.23) years older (P < .001) and had higher rates of hypertension (OR, 1.89 [95% CI, 1.57-2.27]; P < .001) and diabetes (OR, 1.16 [95% CI, 1.02-1.31]; P = .02). Overall, there were comparable rates of mRS scores of 0 to 2 between patients with AF and patients without AF (odds ratio [OR], 0.72 [95% CI, 0.47-1.10]; P = .13), with significant heterogeneity among the included studies. After sensitivity analysis, the rate of mRS scores of 0 to 2 was significantly lower among patients with AF (OR, 0.65 [95% CI, 0.52-0.81]; P < .001). Successful reperfusion rates were similar between the groups (OR, 1.11 [95% CI, 0.78-1.58]; P = .57). The rate of SICH was similar between groups (OR, 1.05 [95% CI, 0.84-1.31]; P = .68). Mortality was significantly higher in the AF group (OR, 1.47 [95% CI, 1.12-1.92]; P = .005).

CONCLUSIONS AND RELEVANCE: In this systematic review and meta-analysis, patients with AF experienced worse 90-day outcomes, even in the setting of similar rates of successful reperfusion. This was likely associated with greater age and greater rates of comorbidities among patients with AF.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Kobeissi H, Ghozy S, Seymour T, et al. Outcomes of Patients With Atrial Fibrillation Following Thrombectomy for Stroke: A Systematic Review and Meta-analysis. JAMA Netw Open. 2023. PMID: 36607633. doi:10.1001/jamanetworkopen.2022.49993

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。